| 11065219 |
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones |
Roshantha A. Chandraratna |
2021-07-20 |
| 10987330 |
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones |
Roshantha A. Chandraratna |
2021-04-27 |
| 10980759 |
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones |
Roshantha A. Chandraratna |
2021-04-20 |
| 10980760 |
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones |
Roshantha A. Chandraratna |
2021-04-20 |
| 10980761 |
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones |
Roshantha A. Chandraratna |
2021-04-20 |
| 10973791 |
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones |
Roshantha A. Chandraratna |
2021-04-13 |
| 10966950 |
Use of an RXR agonist in treating HER2+ cancers |
Powel H. Brown |
2021-04-06 |
| 10946001 |
Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones |
Roshantha A. Chandraratna |
2021-03-16 |
| 10881628 |
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy |
Roshantha A. Chandraratna |
2021-01-05 |
